Market news — every asset we track

Assets

CPRX

Angelini Pharma Completes Acquisition of Catalyst Pharmaceuticals

The Italian pharma company grows its presence in the U.S. market and strengthens its global leadership in Brain Health and Rare DiseasesCompletion of the transaction gives Angelini Pharma ownership of Catalyst’s product portfolioThe transaction is being carried out with the participation of funds managed by BlackstoneCDP Equity approves €1 billion investment in Angelini PharmaItaly remains a strategic production and scientific hub ROME and CORAL GABLES, Fla., July 16, 2026 (GLOBE NEWSWIRE) -- An

Jul 16Yahoo Finance

CPRX

Catalyst Pharmaceuticals Stockholders Clear Angelini Pharma Merger

Catalyst Pharmaceuticals (NASDAQ:CPRX) stockholders approved the company’s proposed merger with Angelini Pharma S.p.A. at a special meeting held virtually on July 8, according to remarks from company officials during the meeting. Patrick J. McEnany, chairman of Catalyst’s board of directors, presid

Jul 10Yahoo Finance

CPRX

Catalyst Pharma Shareholders Approve Angelini Merger Agreement

Detailed price information for Catalyst Pharm Inc (CPRX-Q) from The Globe and Mail including charting and trades.

Jul 9The Globe and Mail

CPRX

This is the newest page. Registered accounts read further back.